基本信息 产品详情 公司简介 推荐产品
网站主页 4-Piperidinecarboxamide, 1-[3-[3,4-dihydro-2,4-dioxo-3-(phenylmethyl)pyrido[2,3-d]pyrimidin-1(2H)-yl]propyl]-N-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-
  • CDK9 autophagic degrader 1

CDK9 autophagic degrader 1

新品
CDK9 autophagic degrader 1
询价 10mg 起订
25mg 起订
50mg 起订
浙江 更新日期:2026-09-27

杭州埃米尔生物技术有限公司

VIP1年
联系人:沈忠
电话:19011298796拨打
手机:19011298796 拨打
邮箱:17816380947@139.com

产品详情:

英文名称:
CDK9 autophagic degrader 1
CAS号:
3066836-42-5
品牌:
EMERTH
产地:
Hangzhou
保存条件:
-20°C
纯度规格:
98%
产品类别:
ATTEC

CDK9 autophagic degrader 1 (Compound 28) is a synthetic autophagosome-tethering compound (ATTEC) designed to promote the degradation of CDK9 through the LC3B-dependent autophagy–lysosome pathway. The molecule combines an LC3B-recruiting moiety, a flexible linker, and a CDK9-targeting ligand, enabling the target protein to be recruited to autophagosomes for subsequent lysosomal degradation.

CDK9 autophagic degrader 1 can also affect the level of Cyclin T1, the associated partner of CDK9. It has been reported to show an over 80% CDK9 inhibition rate at 100 nM, making it a useful research compound for studying ATTEC-mediated protein degradation and CDK9/Cyclin T1 biology.

CAS No.: 3066836-42-5
Molecular Formula: C₃₄H₃₉N₇O₄S₂
Molecular Weight: 673.85 g/mol
Product Type: ATTEC / autophagic protein degrader
Target: CDK9
Degradation Pathway: LC3B-dependent autophagy–lysosome pathway
Key Features: LC3B recruiter, linker, CDK9-targeting ligand
Applications: Targeted protein degradation, autophagy research, CDK9/Cyclin T1 research, chemical biology, and cancer research.

ATTEC;CDK9 degrader;lysosome degradation;

公司简介

杭州埃米尔生物技术有限公司位于浙江省杭州市钱塘区下沙街道安和药谷,立足杭州生物医药产业集聚区位优势,专注深耕ADC/XDC 生物偶联技术研发服务、医药小分子中间体定制合成两大核心业务,是聚焦抗体偶联药物上下游研发配套的专业化生物技术初创企业,面向药企、CRO 公司、高校科研院所提供从工艺开发、样品合成到质控分析的一站式技术外包解决方案。

成立日期 (1年)
注册资本 200万人民币
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,试剂,定制,服务
主营行业 合成材料中间体,生物技术服务,技术培训服务,整体实验外包服务

CDK9 autophagic degrader 1相关厂家报价

内容声明
拨打电话 立即询价